LCDRD

Levy CIMAR's Laboratory for Combinatorial Drug Regimen Design (LCDRD)

Advanced Facilities for Cutting-Edge Research Offering Fee-for-Service Contracts.

Learn More
Featured Trainees

Levy CIMAR's Featured Trainees

Here we highlight trainees (students and professionals) who stand out for their efforts in the fight against antimicrobial resistance.

Learn More
Education

Reaching Out to Brockton High

33 Sophomores and Seniors presented their original experiments and data on AMR to a wide audience at Tufts University and Tufts Medical Center.

Our Programs
CIMAR

Levy CIMAR

Innovating to Protect Humanity from the Global Threat of Antimicrobial Resistance: Integrating Solutions Across Human and Veterinary Medicine, Stewardship, and Awareness.

Join Us
Research

Multidrug Therapies

Using Combination Chemotherapies to Cure Otherwise Untreatable Infections.

Explore Research

Our Mission

Innovating to Protect Humanity from the Global Threat of Antimicrobial Resistance: Integrating Solutions Across Human and Veterinary Medicine, Stewardship, and Awareness

—  Latest Updates

News

Levy CIMAR's New Research Hub to Tackle Antimicrobial Resistance

How the Pandemic Gave Power to Superbugs: Tufts Dean Weighs In

You and Your Pet Can Share Resistance to Certain Medications. Here’s How.

Events

Metabolic Modeling Predicts Unique Drug Targets in Lyme Disease Pathogen B. burgdorferi – TUSM’s Peter Gwynne, PhD

April 8, 2026

We were pleased to hear from Bryan Lenneman, Ph.D., today on “Engineering Phages as Novel Antimicrobials Targeting Gram-Negative Pathogens.” Dr. Lenneman is a Research Fellow at Massachusetts General Hospital whose research interests include utilizing synthetic biology to develop novel therapeutics against diseases associated with dysbiosis of the human gut microbial community.

Engineering Phages as Novel Antimicrobials Targeting Gram-Negative Pathogens – Massachusetts General Hospital’s Bryan Lenneman, Ph.D.

April 8, 2026

MGH Research Fellow Bryan Lenneman, PhD, is interested in utilizing synthetic biology to develop novel therapeutics against diseases associated with dysbiosis of the human gut microbial community.

Diagnostic Stewardship as a Tool for Antimicrobial Stewardship – Tufts Medical Center’s Shira Doron, MD

April 8, 2026

Levy CIMAR’s own Shira Doron, MD, presented for this month’s Science Seminar on the topic of “Diagnostic Stewardship as a Tool for Antimicrobial Stewardship.” Dr. Doron is a widely recognized expert in the fields of antimicrobial and diagnostic stewardship, and among her many titles, is Chief Infection Control Officer for Tufts Medicine. There, she Infection Control and Antimicrobial Stewardship.

Our Trainees

Maryam Utegulova

Maryam Utegulova

Maryam Utegulova, 2025 Recipient of the Levy CIMAR Undergraduate Summer Internship in Science and Medicine

Mallika Subramanian

Mallika Subramanian

Mallika Subramanian, 2025 Recipient of the Levy CIMAR Undergraduate Summer Internship in Science and Medicine

Asli Dirik

Asli Dirik

Asli Dirik, Tufts IDoc Student Specializing in Bioresponsive Materials and Wearable Interfaces for Monitoring Female Health

Publications

Antibiotic allergy prevalence and documentation quality in Massachusetts long-term care facilities: A cross-sectional survey

Kap Sum Foong, MD , Leslie Fowle, MPH, Shira Doron, MD, Melissa Cumming, MS, Jessica Leaf, MPH, Barbara Bolstorff, MS, Christina Brandeburg, MPH, Ye Chen, MS, Alysse Wurcel, MD, MS

Ann Allergy Asthma…

Dipping Your Toe in The CURE Pool: Longitudinal Tracking of Instructors Suggests Use of a Short-Duration CURE Can Catalyze Expansion to Longer CURE Experiences

Elizabeth Genné-Bacon, Michal Fux, Sara A. Bove, Finn Payne, Georgia Xenakis, John D. Coley, and Carol Bascom-Slack

CBE Life Sci Educ. 2024 Sep;23(3):ar31.

The impact of 30-day antecedent antibiotic exposure on Clostridioides difficile ribotype patterns and the relationship with clinical outcomes: A single center study

Majd Alsoubani, Jennifer K Chow, Angie Mae Rodday, Laura A McDermott, Seth T Walk, David R Snydman

Anaerobe. 2024 Aug 8:89:102894. Online ahead of print.

Blocking HXA3-mediated neutrophil elastase release during S. pneumoniae lung infection limits pulmonary epithelial barrier disruption and bacteremia

Shuying Xu, Shumin Tan, Patricia Romanos, Jennifer L. Reedy, Yihan Zhang, Michael K. Mansour, Jatin M. Vyas, Joan Mecsas, Hongmei Mou, John M. Leong

mBio. 2024 Aug 9:e0185624. Online ahead of print.

Join us on Socials

Our Values

The Levy CIMAR is committed to a culture of diversity, equity, and inclusion both within our organization and for all people who are impacted by our work. We strive for health equity for people from all backgrounds and identities, and we actively support societal and institutional structures that promote justice and equality. We are also committed to being a safe, respectful, and inclusive environment for our trainees, staff, faculty, affiliates, and partners. One Health acknowledges the interconnectedness of allhumans, along with animals and our environments. Antimicrobial resistance impacts us all.